Optogenetic Gs030 Therapy In Subjects With Retinitis Pigmentosa: Safety And Tolerability Up To Two Years After Treatment Administration In The Phase 1/2a Pioneer Study
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2021)
关键词
optogenetic gs030 therapy,retinitis pigmentosa,treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要